Diagnosis and treatment of influenza based on health insurance claims between the 2010–2011 and 2019–2020 influenza seasons in Japan

Medical practices for influenza virus infection vary among countries. In Japan, treatment with anti‐influenza drugs is recommended for patients diagnosed with influenza. This health claims database study provides quantitative information aimed at describing the actual medical practices, including di...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimizu, Eiko, Iwasaki, Kosuke, Hongo, Yoshie, Yoshida, Manami, Kinoshita, Masahiro, Hiroi, Shinzo, Tamura, Daisuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178068/
https://www.ncbi.nlm.nih.gov/pubmed/35297196
http://dx.doi.org/10.1111/irv.12977
_version_ 1784722975105220608
author Shimizu, Eiko
Iwasaki, Kosuke
Hongo, Yoshie
Yoshida, Manami
Kinoshita, Masahiro
Hiroi, Shinzo
Tamura, Daisuke
author_facet Shimizu, Eiko
Iwasaki, Kosuke
Hongo, Yoshie
Yoshida, Manami
Kinoshita, Masahiro
Hiroi, Shinzo
Tamura, Daisuke
author_sort Shimizu, Eiko
collection PubMed
description Medical practices for influenza virus infection vary among countries. In Japan, treatment with anti‐influenza drugs is recommended for patients diagnosed with influenza. This health claims database study provides quantitative information aimed at describing the actual medical practices, including diagnostic testing and medication use, for managing influenza in Japan. Most patients diagnosed with influenza underwent diagnostic tests and were prescribed anti‐influenza drugs. Meanwhile, the majority of patients prescribed anti‐influenza drugs had undergone diagnostic testing. However, an increase in the percentage of anti‐influenza prescriptions without diagnostic testing was observed during the 2019–2020 influenza season, which may be associated with the COVID‐19 pandemic.
format Online
Article
Text
id pubmed-9178068
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-91780682022-07-01 Diagnosis and treatment of influenza based on health insurance claims between the 2010–2011 and 2019–2020 influenza seasons in Japan Shimizu, Eiko Iwasaki, Kosuke Hongo, Yoshie Yoshida, Manami Kinoshita, Masahiro Hiroi, Shinzo Tamura, Daisuke Influenza Other Respir Viruses Short Communications Medical practices for influenza virus infection vary among countries. In Japan, treatment with anti‐influenza drugs is recommended for patients diagnosed with influenza. This health claims database study provides quantitative information aimed at describing the actual medical practices, including diagnostic testing and medication use, for managing influenza in Japan. Most patients diagnosed with influenza underwent diagnostic tests and were prescribed anti‐influenza drugs. Meanwhile, the majority of patients prescribed anti‐influenza drugs had undergone diagnostic testing. However, an increase in the percentage of anti‐influenza prescriptions without diagnostic testing was observed during the 2019–2020 influenza season, which may be associated with the COVID‐19 pandemic. John Wiley and Sons Inc. 2022-03-17 2022-07 /pmc/articles/PMC9178068/ /pubmed/35297196 http://dx.doi.org/10.1111/irv.12977 Text en © 2022 The Authors. Influenza and Other Respiratory Viruses published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Communications
Shimizu, Eiko
Iwasaki, Kosuke
Hongo, Yoshie
Yoshida, Manami
Kinoshita, Masahiro
Hiroi, Shinzo
Tamura, Daisuke
Diagnosis and treatment of influenza based on health insurance claims between the 2010–2011 and 2019–2020 influenza seasons in Japan
title Diagnosis and treatment of influenza based on health insurance claims between the 2010–2011 and 2019–2020 influenza seasons in Japan
title_full Diagnosis and treatment of influenza based on health insurance claims between the 2010–2011 and 2019–2020 influenza seasons in Japan
title_fullStr Diagnosis and treatment of influenza based on health insurance claims between the 2010–2011 and 2019–2020 influenza seasons in Japan
title_full_unstemmed Diagnosis and treatment of influenza based on health insurance claims between the 2010–2011 and 2019–2020 influenza seasons in Japan
title_short Diagnosis and treatment of influenza based on health insurance claims between the 2010–2011 and 2019–2020 influenza seasons in Japan
title_sort diagnosis and treatment of influenza based on health insurance claims between the 2010–2011 and 2019–2020 influenza seasons in japan
topic Short Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178068/
https://www.ncbi.nlm.nih.gov/pubmed/35297196
http://dx.doi.org/10.1111/irv.12977
work_keys_str_mv AT shimizueiko diagnosisandtreatmentofinfluenzabasedonhealthinsuranceclaimsbetweenthe20102011and20192020influenzaseasonsinjapan
AT iwasakikosuke diagnosisandtreatmentofinfluenzabasedonhealthinsuranceclaimsbetweenthe20102011and20192020influenzaseasonsinjapan
AT hongoyoshie diagnosisandtreatmentofinfluenzabasedonhealthinsuranceclaimsbetweenthe20102011and20192020influenzaseasonsinjapan
AT yoshidamanami diagnosisandtreatmentofinfluenzabasedonhealthinsuranceclaimsbetweenthe20102011and20192020influenzaseasonsinjapan
AT kinoshitamasahiro diagnosisandtreatmentofinfluenzabasedonhealthinsuranceclaimsbetweenthe20102011and20192020influenzaseasonsinjapan
AT hiroishinzo diagnosisandtreatmentofinfluenzabasedonhealthinsuranceclaimsbetweenthe20102011and20192020influenzaseasonsinjapan
AT tamuradaisuke diagnosisandtreatmentofinfluenzabasedonhealthinsuranceclaimsbetweenthe20102011and20192020influenzaseasonsinjapan

Ejemplares similares